LORRAINE HARRIS: Open Payments
NPI 1487828018 · PENNSAUKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,432 in 44 payments from 17 companies in 2025. Trend: 2023 $602 · 2024 $637 · 2025 $1,432
Food & beverage: $1,333Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $361 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $231 |
| Lilly USA, LLC | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $123 |
| Exact Sciences Corporation | 4 | $111 |
| Novo Nordisk Inc | 1 | $109 |
| Biogen, Inc. | 1 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Exeltis, USA Inc. | 3 | $45 |
| Merck Sharp & Dohme LLC | 2 | $29 |
Products named: Veozah, ZEPBOUND, Yeztugo, ZURZUVAE, Cologuard Collection Kit, Ozempic, BIJUVA, SLYND.
Industry payments across NJ — which companies pay providers there.
